Clinical Trial Update: Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention [Phase 2]

View source ↗

Summary

Phase 2 safety data for PZ-128 in subjects undergoing non-emergent percutaneous coronary intervention have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease
• Coronary Syndrome
• Myocardial Ischemia

Drugs mentioned

• PZ-128

Snippet

Sponsor: Tufts Medical Center | Conditions: Arterial Occlusive Diseases, Coronary Artery Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-03-09